Clinical Trials Browser

Withdrawn × Multiple Myeloma × liposomal doxorubicin × Clear all

NCT00706953 2015-04-06

A Study of Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With Bortezomib

Phase 2 Withdrawn

Multiple Myeloma, Recurrence

NCT01492881 2012-05-11

Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma